CASR and lung adenocarcinoma: In lung adenocarcinoma, CaSR was overexpressed in patients with bone metastasis, and overexpression of CaSR increased NF-κB protein levels and subsequent matrix metalloproteinases 2 and 9 to enhance tumor cell invasion [120].